UrologyNews.net

Urology Xagena

Xagena Mappa
Medical Meeting
Mediexplorer.it
Farmaexplorer.it

Search results for "Radium-223"

Data from the pivotal Phase III ALSYMPCA ( ALpharadin in SYMptomatic Prostate CAncer ) trial of its drug Radium 223 dichloride ( Radium 223 ) in castration-resistant prostate cancer patients with symp ...


Radium-223 dichloride ( Ra-233; Xofigo ), a bone targeting alpha radiopharmaceutical, and Enzalutamide ( Xtandi ), are approved for metastatic castration refractory prostate cancer ( mCRPC ). Per SW ...